Table 3 Patient demographics and disease characteristics in treatment group.

From: Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy

Characteristics

All (N = 30)

%

Median age (range), years

35 (18–52)

 

Age

≤35 years

17

56.67

>35 years

13

43.33

Sex

Male

11

36.67

Female

19

63.33

Primitive volume of the largest renal AML

≤200 cm3

18

60.00

>200 cm3

12

40.00

TSC1 or TSC2 mutation

With mutation

5

16.67

None mutation

14

46.67

Unknown

11

36.67

Back to article page